AltraVue Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,797,813
| Closed | -$46.9M | – | 28 |
|
|
2024
Q4 | $46.9M | Hold |
3,797,813
| – | – | 3.91% | 9 |
|
|
2024
Q3 | $43.2M | Buy |
3,797,813
+402,550
| +12% | +$4.04M | 3.89% | 11 |
|
|
2024
Q2 | $24.2M | Buy |
3,395,263
+239,343
| +8% | +$1.83M | 2.41% | 16 |
|
|
2024
Q1 | $21.1M | Buy |
3,155,920
+181,587
| +6% | +$1.25M | 2.29% | 16 |
|
|
2023
Q4 | $19.3M | Sell |
2,974,333
-34,856
| -1% | -$225K | 2.23% | 19 |
|
|
2023
Q3 | $28.4M | Sell |
3,009,189
-721,782
| -19% | -$8.69M | 3.38% | 15 |
|
|
2023
Q2 | $52.1M | Buy |
3,730,971
+15,090
| +0.4% | +$257K | 6.13% | 4 |
|
|
2023
Q1 | $69.7M | Buy |
3,715,881
+412,921
| +13% | +$6.78M | 8.37% | 1 |
|
|
2022
Q4 | $45.5M | Buy |
3,302,960
+618,000
| +23% | +$9.47M | 6.37% | 3 |
|
|
2022
Q3 | $51.3M | Sell |
2,684,960
-50,280
| -2% | -$916K | 7.68% | 2 |
|
|
2022
Q2 | $41.7M | Buy |
2,735,240
+481,874
| +21% | +$7.13M | 6.14% | 3 |
|
|
2022
Q1 | $45.9M | Buy |
2,253,366
+270
| +0% | +$5.5K | 6.24% | 3 |
|
|
2021
Q4 | $65.7M | Sell |
2,253,096
-211,220
| -9% | -$6.04M | 8.7% | 1 |
|
|
2021
Q3 | $53.2M | Buy |
2,464,316
+277,360
| +13% | +$6.7M | 7.86% | 1 |
|
|
2021
Q2 | $56.1M | Sell |
2,186,956
-153,244
| -7% | -$3.27M | 9.94% | 1 |
|
|
2021
Q1 | $42.7M | Buy |
2,340,200
+92,405
| +4% | +$1.54M | 9.44% | 1 |
|
|
2020
Q4 | $25.9M | Sell |
2,247,795
-70,235
| -3% | -$642K | 7.73% | 1 |
|
|
2020
Q3 | $17.7M | Buy |
2,318,030
+384,215
| +20% | +$2.91M | 8.25% | 1 |
|
|
2020
Q2 | $12.7M | Sell |
1,933,815
-16,540
| -0.8% | -$92.3K | 9.52% | 2 |
|
|
2020
Q1 | $9.97M | Sell |
1,950,355
-261,087
| -12% | -$1.58M | 8.23% | 4 |
|
|
2019
Q4 | $17M | Sell |
2,211,442
-11,940
| -0.5% | -$69.7K | 8.43% | 1 |
|
|
2019
Q3 | $11.8M | Buy |
2,223,382
+114,570
| +5% | +$711K | 6.48% | 2 |
|
|
2019
Q2 | $11.8M | Buy |
2,108,812
+133,337
| +7% | +$550K | 6.53% | 2 |
|
|
2019
Q1 | $8.4M | Buy |
1,975,475
+655,507
| +50% | +$2.67M | 4.75% | 4 |
|
|
2018
Q4 | $5.41M | Buy |
+1,319,968
| New | +$6.89M | 3.4% | 7 |
|
Other funds holding CDMO
AltraVue Capital's CDMO Position: Q1 2025 in Review
AltraVue Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 3,797,813 shares — an estimated $46.9M sold.
AltraVue Capital first reported a position in CDMO in Q4 2018 and held it in 25 quarters. The position peaked at $69.7M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- AltraVue Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- AltraVue Capital sold 3,797,813 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $46.9M.
- AltraVue Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 25 quarters.
- AltraVue Capital's Avid Bioservices, Inc. Common Stock position peaked at $69.7M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on AltraVue Capital's 13F filing for Q1 2025, filed 13 May 2025.